What's breaking now, across thousands of outlets.
Novo Nordisk stock jumped higher on Wednesday as the Danish drugmaker lifted its guidance on strong uptake of its weight-loss drug pill that has been launched this year.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Novo Nordisk A/S Chief Executive Officer Mike Doustdar discusses the possible launch of a new obesity drug called CagriSema.
Bitwise’s André Dragosch attributed Bitcoin ETF outflows to weaker market sentiment, saying institutions have largely maintained their exposure.
Morgan Stanley said it converted US equities and Treasurys into tokenized form through DTCC's new tokenization service.
Hedge funds reduced leverage at the fastest pace since March as sharp losses across fundamental and systematic strategies triggered widespread de-risking and heavy selling of technology stocks in…
The company attributed the growth to its micro-drama business, which contributed Rs 293 crore in subscription revenue in its first full year.
Warren Buffett believes market drawdowns are a good opportunity to buy quality stocks at discounted prices.
